Shares of Etsy Inc (NYSE:ETSY) rose sharply in pre-market trading after the company entered into an agreement to sell Depop.Etsy and eBay (NASDAQ:EBAY) have entered into a definitive agreement under which eBay will acquire Etsy's fashion marketplace Depop for approximately $1.2 billion in cash.Etsy shares jumped 15.5% to $50.86 in the pre-market trading session.Here are some other stocks moving in pre-market trading.GainersLosersPhoto via Shutterstock ...

Group 1: Market Overview - The stock market has seen notable gains across various sectors, including technology, healthcare, and energy [1][6] - Recent movements highlight the dynamic nature of the stock market, driven by technological advancements, healthcare innovations, and strategic corporate activities [6] Group 2: Company Highlights - New Era Energy & Digital, Inc. (NASDAQ:NUAI) leads with an 88.96% increase, reaching $2.91, driven by its innovative approach in helium, oil, and natural gas exploration [1][7] - Bluejay Diagnostics, Inc. (NASDAQ:BJDX) follows with an 86.64% rise to $3.49, fueled by its Symphony platform and diagnostic tests, along with an expanded partnership with SanyoSeiko Co., Ltd. [2][7] - Lakeshore Acquisition III Corp. Rights (NASDAQ:LCCCR) saw an 81.82% increase to $0.4, reflecting speculative trading often associated with shell companies and potential upcoming acquisitions [3][7] - Turn Therapeutics Inc. (NASDAQ:TTRX) experienced a 56.39% rise to $10.94, focusing on dermatology and wound care, with an upcoming Nasdaq listing indicating positive developments [4][7] - AtlasClear Holdings, Inc. (NASDAQ:ATCH) saw a 50.59% increase to $0.54, supported by a recent $20 million financing, reflecting market optimism about its future prospects [5][7]

Market Overview - U.S. stocks traded mixed, with the Nasdaq Composite falling over 50 points on Thursday. The Dow increased by 0.09% to 46,642.93, while the Nasdaq decreased by 0.25% to 22,985.10, and the S&P 500 fell by 0.07% to 6,749.15 [1] - Energy shares rose by 0.6% on Thursday [1] Sector Performance - Consumer discretionary stocks fell by 0.9% on Wednesday [2] Company Earnings - PepsiCo, Inc. reported better-than-expected third-quarter earnings, with adjusted earnings per share of $2.29, surpassing the analyst consensus estimate of $2.26. Quarterly sales reached $23.937 billion, reflecting a 2.6% year-over-year increase, exceeding the expected $23.827 billion [3] Commodity Prices - Oil prices increased by 0.1% to $62.55, while gold prices decreased by 0.4% to $4,055.60. Silver fell by 0.2% to $48.90, and copper rose by 2.2% to $5.2080 [5] International Markets - European shares showed mixed results, with the eurozone's STOXX 600 falling by 0.2%, Spain's IBEX 35 Index down by 0.6%, London's FTSE 100 down by 0.2%, Germany's DAX 40 up by 0.4%, and France's CAC 40 gaining 0.2% [6] - Asian markets closed mostly higher, with Japan's Nikkei 225 gaining 1.77%, China's Shanghai Composite up by 1.32%, and India's BSE Sensex rising by 0.49% [7] Stock Movements - Turn Therapeutics Inc. shares surged by 202% to $21.17 after commencing trading on the Nasdaq Capital Market. Bluejay Diagnostics, Inc. shares increased by 110% to $3.9300 following a strategic partnership expansion. EPWK Holdings Ltd. shares rose by 70% to $0.1261 [9] - Conversely, Vantage Corp shares dropped by 71% to $1.85, and Universe Pharmaceuticals INC shares fell by 29% to $6.70 after a previous surge [9]

Market Overview - U.S. stocks traded mixed, with the Nasdaq Composite falling more than 50 points on Thursday. The Dow increased by 0.09% to 46,642.93, while the Nasdaq decreased by 0.25% to 22,985.10, and the S&P 500 fell by 0.07% to 6,749.15 [1] - Energy shares rose by 0.6% on Thursday [1] Sector Performance - Consumer discretionary stocks fell by 0.9% on Wednesday [2] Company Earnings - PepsiCo, Inc. reported better-than-expected third-quarter earnings, with adjusted earnings per share of $2.29, surpassing the analyst consensus estimate of $2.26. Quarterly sales reached $23.937 billion, reflecting a 2.6% year-over-year increase, exceeding the expected $23.827 billion [3] Commodity Prices - Oil prices increased by 0.1% to $62.55, while gold prices decreased by 0.4% to $4,055.60. Silver fell by 0.2% to $48.90, and copper rose by 2.2% to $5.2080 [5] Global Market Performance - European shares were mixed, with the eurozone's STOXX 600 falling by 0.2%, Spain's IBEX 35 Index down by 0.6%, London's FTSE 100 down by 0.2%, Germany's DAX 40 up by 0.4%, and France's CAC 40 gaining 0.2% [6] - Asian markets closed mostly higher, with Japan's Nikkei 225 gaining 1.77%, China's Shanghai Composite up by 1.32%, and India's BSE Sensex rising by 0.49% [7] Stock Movements - Turn Therapeutics Inc. shares surged by 202% to $21.17 after commencing trading on the Nasdaq Capital Market. Bluejay Diagnostics, Inc. shares increased by 110% to $3.9300 following a strategic partnership expansion. EPWK Holdings Ltd. shares rose by 70% to $0.1261 [9] - Conversely, Vantage Corp shares dropped by 71% to $1.85, and Universe Pharmaceuticals INC shares fell by 29% to $6.70 after a previous surge [9]

Core Insights - Premarket trading is showing notable activity with significant price movements indicating potential trading opportunities before the market opens [1] Premarket Gainers - Galecto, Inc. (GLTO) has seen a remarkable increase of 726%, trading at $30.67 [3] - C3is Inc. (CISS) is up 55%, currently priced at $3.43 [3] - Spruce Biosciences, Inc. (SPRB) has risen by 41%, trading at $184.00 [3] - Lexeo Therapeutics, Inc. (LXEO) is up 32%, priced at $8.60 [3] - Bluejay Diagnostics, Inc. (BJDX) has increased by 30%, trading at $2.03 [3] - Datavault AI Inc. (DVLT) is up 24%, currently at $2.58 [3] - Diginex Limited (DGNX) has risen by 13%, trading at $22.56 [3] - Global Interactive Technologies, Inc. (GITS) is up 13%, priced at $2.55 [3] - Odyssey Marine Exploration, Inc. (OMEX) has increased by 12%, trading at $3.00 [3] - AXIL Brands, Inc. (AXIL) is up 9%, currently at $6.16 [3] Premarket Losers - Society Pass Incorporated (SOPA) has decreased by 25%, trading at $3.94 [4] - SANUWAVE Health, Inc. (SNWV) is down 18%, currently priced at $33.30 [4] - Aehr Test Systems, Inc. (AEHR) has fallen by 18%, trading at $25.95 [4] - Aether Holdings, Inc. (ATHR) is down 16%, priced at $4.55 [4] - Dermata Therapeutics, Inc. (DRMA) has decreased by 13%, trading at $4.66 [4] - Lazydays Holdings, Inc. (GORV) is down 12%, currently at $2.55 [4] - OneMedNet Corporation (ONMD) has fallen by 11%, trading at $2.26 [4] - KORE Group Holdings, Inc. (KORE) is down 10%, priced at $2.53 [4] - Biomea Fusion, Inc. (BMEA) has decreased by 10%, trading at $2.38 [4] - CPS Technologies Corporation (CPSH) is down 9%, currently at $3.40 [4]

Core Insights - Bluejay Diagnostics, Inc. announced the acceptance of an abstract for the Symphony IL-6 Test at the SAEM Annual Meeting, highlighting its potential in sepsis management [1][2] - The SYMON-I study results will be presented, focusing on IL-6 as a prognostic biomarker for mortality in sepsis patients [1][4] Company Overview - Bluejay Diagnostics is focused on developing rapid and accessible biomarker testing, with its lead product being the Symphony IL-6 Test for sepsis triage [5] - The Symphony IL-6 Test aims to provide results in approximately 20 minutes, assisting healthcare professionals in making timely treatment decisions [5] Clinical Study Details - The SYMON Clinical Study Program includes SYMON-I and SYMON-II, with SYMON-I being a pilot study assessing IL-6 levels related to various mortality endpoints [4] - SYMON-II is a pivotal study intended to validate SYMON-I outcomes and support a 510(k) application to the FDA [4] Presentation Information - The presentation titled "Multicenter Symphony IL-6 Monitoring Sepsis ICU Validation Study (SYMON I)" will take place on May 14, 2025, by presenters John H. Lee, M.D., Ph.D. and Nathan Shapiro, M.D. [3]

Core Viewpoint - Bluejay Diagnostics, Inc. has entered into an agreement with existing institutional investors to exercise warrants for common stock, raising approximately $3.7 million in gross proceeds at a reduced exercise price of $3.42 per share [1][2]. Company Overview - Bluejay Diagnostics, Inc. is a medical technology company focused on developing rapid diagnostics through its Symphony platform to enhance patient outcomes in critical care settings [1][5]. - The company's first product candidate is an IL-6 Test for sepsis, designed to deliver accurate results in about 20 minutes, aiding medical professionals in making timely treatment decisions [5]. Financial Transaction Details - Investors will receive new warrants to purchase an equal number of shares (1,085,106) at the same exercise price of $3.42, which are exercisable immediately and will expire in five years [2]. - The transaction was facilitated by Aegis Capital Corp. as the exclusive financial advisor, with legal counsel provided by Hogan Lovells US LLP for the company and Kaufman & Canoles, P.C. for Aegis Capital Corp. [4].